Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase μ

Biochemical Pharmacology

Volumn 58, Issue 4, 1999, Pages 693-702

  Horton, Julie K ^a   Roy, Gargi ^b   Piper, John T ^c   Van Houten, Bennett ^b,c   Awasthi, Yogesh C ^c   Mitra, Sankar ^b,c   Alaoui Jamali, Moulay A ^d   Boldogh, Istvan ^c   Singhal, Sharad S ^c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Chlorambucil; Drug resistance; Glutathione S transferase; Ovarian carcinoma

Indexed keywords

CARMUSTINE; CHLORAMBUCIL; CISPLATIN; DOXORUBICIN; GLUTATHIONE TRANSFERASE; MELPHALAN; MITOMYCIN C; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DNA DAMAGE; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, ALKYLATING; CATALYSIS; CELL DIVISION; CHLORAMBUCIL; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; ENZYME INDUCTION; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; METABOLIC DETOXICATION, DRUG; OVARIAN NEOPLASMS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0033567422     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00142-2     Document Type: Article

References (42)

1. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 62:1993;385-427.
2. Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M.V., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
3. DeVita VT, Principles of Chemotherapy. J.B. Lippincott, Philadelphia, 1993.
4. Lawley P.D., Phillips D.H. DNA adducts from chemotherapeutic agents. Mutat Res. 355:1996;13-40.
5. Yen L., Woo A., Christopoulopoulos G., Batist G., Panasci L., Roy R., Mitra S., Alaoui-Jamali M.A. Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents. Mutat Res. 337:1995;179-189.
6. Vistica D.T. Cytotoxicity as an indicator for transport mechanism Evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell . Biochim Biophys Acta. 550:1979;309-317.
7. Connors T.A., Cox P.J., Farmer P.B., Foster A.B., Jarman M. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem Pharmacol. 23:1974;115-129.
8. Alaoui-Jamali M.A., Panasci L., Centurioni G.M., Schector R., Lehnert S., Batist G. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione S-transferase activity. Cancer Chemother Pharmacol. 30:1992;341-347.
9. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance . Crit Rev Biochem Mol Biol. 30:1995;445-600.
10. Dulik D.M., Colvin O.M., Fenselau C. Characterization of glutathione conjugates of chlorambucil by fast atom bombardment and thermospray liquid chromatography/mass spectrometry. Biomed Environ Mass Spectrom. 19:1990;248-252.
11. Dulik D.M., Fenselau C., Hilton J. Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases. Biochem Pharmacol. 35:1986;3405-3409.
12. Vahrmeijer A.L., Snel C.A.W., Steenvoorden D.P.T., Beijnen J.H., Pang K.S., Schutrups J., Tirona R., Keizer H.J., van Dierendonck J.H., van de Velde C.J.H., Mulder G.J. Lack of glutathione conjugation of melphalan in the isolated in situ liver perfusion in humans. Cancer Res. 56:1996;4709-4714.
13. Yang W.Z., Begleiter A., Johnston J.B., Israels L.G., Mowat M.R. Role of glutathione and glutathione S-transferase in chlorambucil resistance. Mol Pharmacol. 41:1992;625-630.
14. Morgan A.S., Ciaccio P.J., Tew K.D., Kauvar L.M. Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother Pharmacol. 37:1996;363-370.
15. Morrow C.S., Cowan K.H. Antineoplastic drug resistance and breast cancer. Ann NY Acad Sci. 698:1993;289-312.
16. Schecter R.L., Alaoui-Jamali M.A., Woo A., Fahl W.E., Batist G. Expression of rat glutathione S-transferase complementary DNA in rat mammary carcinoma cells Impact upon alkylator-induced toxicity . Cancer Res. 53:1993;4900-4906.
17. Bank B.B., Kanganis D., Liebes L.F., Silber R. Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes. Cancer Res. 49:1989;554-559.
18. McLean A., Woods R.L., Catovsky D., Farmer P. Pharmacokinetics and metabolism of chlorambucil in patients with malignant disease. Cancer Treat Rev. 6:1979;33-42.
19. Schisselbauer J.C., Silber R., Papadopoulos E., Abrams K., LaCreta F.P., Tew K.D. Characterization of glutathione S-transferase in lymphocytes from chronic lymphocytic leukemia patients. Cancer Res. 50:1990;3562-3568.
20. Ali-Osman F., Antoun G., Wang H., Rajagopal S., Gagucas E. Buthionine sulfoximine induction of γ-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells. Mol Pharmacol. 49:1996;1012-1020.
21. Zimniak P., Singhal S.S., Srivastava S.K., Awasthi S., Sharma R., Hayden J.B., Awasthi Y.C. Estimation of genomic complexity, heterologous expression, and enzymatic characterization of mouse glutathione S-transferase mGSTA4-4 (GST 5.7). J Biol Chem. 269:1994;992-1000.
22. Singhal S.S., Saxena M., Ahmad H., Awasthi S., Haque A.K., Awasthi Y.C. Glutathione S-transferases of human lung Characterization and evaluation of the protective role of the α-class isozymes against lipid peroxidation . Arch Biochem Biophys. 299:1992;232-241.
23. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases The first enzymic step in mercapturic acid formation . J Biol Chem. 249:1974;7130-7139.
24. Floreani M., Petrone M., Debetto P., Palatini P. A comparison between different methods for the determination of reduced and oxidized glutathione in mammalian tissues. Free Radic Res. 26:1997;449-455.
25. Yakes F.M., Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 94:1997;514-519.
26. Sariban E., Kohn K.W., Zlotogorski C., Laurent G., D'Incalci M., Day R. III, Smith B.H., Kornblith P.L., Erickson L.C. DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaziquone. Cancer Res. 47:1987;3988-3994.
27. Ciaccio P.J., Tew K.D., LaCreta F.P. Enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferases and inhibition by ethacrynic acid. Biochem Pharmacol. 42:1991;1504-1507.
28. Green J.A., Robertson L.J., Clark A.H. Glutathione S-transferase expression in benign and malignant ovarian tumors. Br J Cancer. 68:1993;235-239.
29. Tew K.D., Monks A., Barone L., Rosser D., Akerman G., Montall J.A., Wheatley J.B., Schmidt D.E. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening program. Mol Pharmacol. 50:1996;149-159.
30. Cheng X., Kigawa J., Minagawa Y., Kanamori Y., Itamochi H., Okada M., Terakawa N. Glutathione S-transferase-π expression and glutathione concentration in ovarian carcinoma before and after chemotherapy. Cancer. 79:1997;521-527.
31. Awasthi S., Bajpai K.K., Piper J.T., Singhal S.S., Ballatore A., Seifert W.E., Awasthi Y.C., Ansari G.A.S. Interactions of melphalan and glutathione and the role of glutathione S-transferases. Drug Metab Dispos. 24:1996;371-374.
32. Xu S.-J., Pearson W.R. Characterization of the polymorphic human class mu GSTM1-0 deletion. Vermeulen N.P.E., Mulder G.J., Nieuwenhuyse H., Peters W.H., Van Bladeren P.J.). Glutathione S-transferases Structure, Function and Clinical Implications . 1996;227-238 Taylor & Francis, London.
33. Hall A.G., Matheson E., Hickson I.D., Foster S.A., Hogarth L. Purification of an α class glutathione S-transferase from melphalan-resistant Chinese hamster ovary cell and demonstration of its ability to catalyze melphalan-glutathione adduct formation. Cancer Res. 54:1994;3369-3372.
34. Awasthi S., Sharma R., Singhal S.S., Herzog N.K., Chaubey M., Awasthi Y.C. Modulation of cisplatin cytotoxicity by sulphasalazine. Br J Cancer. 70:1994;190-194.
35. Singh S.V., Xu B.H., Jani J.P., Emerson E.O., Backes M.G., Rihn C., Scalamogna D., Stemmler N., Specht S., Blalock K. Mechanisms of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line. Int J Cancer. 61:1995;431-436.
36. Puchalski R.B., Fahl W.E. Expression of recombinant glutathione S-transferase π, Ya or Yb1 confers resistance to alkylating agents. Proc Natl Acad Sci USA. 87:1990;2443-2447.
37. Ban N., Takahashi Y., Takayama T., Kura T., Katahira T., Sakamaki S., Niitsu Y. Transfection of glutathione S-transferase (GST)-π antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan and etoposide. Cancer Res. 56:1996;3577-3582.
38. Townsend A.J., Tu C.-P.D., Cowan K.H. Expression of human μ or α class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells Effect on cellular sensitivity to cytotoxic agents . Mol Pharmacol. 41:1992;230-238.
39. Nakagawa K., Saijo N., Tsuchida S., Sakai M., Tsunokawa Y., Yokota J., Muramatsu M., Sato K., Terada M., Tew K.D. Glutathione S-transferase π as a determinant of drug resistance in transfectant cell lines. J Biol Chem. 265:1990;4296-4301.
40. Smith M.T., Evans C.G., Doane-Setzer P., Castro V.M., Tahir M.K., Mannervik B. Denitrosation of 1,3-bis(2-chloroethyl)-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain cells. Cancer Res. 49:1989;2621-2625.
41. Seidegard J., Voracheck W.R., Pero R.W., Pearson W.R. Hereditary differences in the expression of human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA. 85:1988;7293-7297.
42. Zwelling L.A., Michaels S., Schwartz H., Dobson P.P., Kohn K.W. DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. Cancer Res. 41:1981;640-649.